Whether front-loaded input cost inflation breaches guided quarterly earnings thresholds, and if retail inventory normalization restores organic volume growth.
Company analysis · produced · reports
Read this as a demonstration of method. This analysis was produced on the date above. Its wording has not been edited since; where the filing has landed, the figures it reported were added beside the thresholds this analysis named. It is published to show how the work is structured, not as a record of predictive accuracy and not as a current view on The Procter & Gamble Company.
Why this event matters
The October 22, 2026 earnings release—reporting Procter & Gamble’s results for the first quarter of fiscal 2027—settles an explicit near-term earnings commitment that management broke regular forecasting protocol to establish. On the fiscal 2026 fourth-quarter earnings call, Chief Financial Officer Andre Schulten departed from P&G's standard policy of avoiding quarterly guidance to warn that core earnings per share (EPS) in the first quarter of fiscal 2027 would decline by "5% or more versus prior year" [transcript:FY2026-Q4]. Against the prior-year baseline of $1.99 in core EPS (and diluted net earnings per common share of $1.95 reported in the first quarter of fiscal 2026) [transcript:FY2026-Q1, 0000080424-25-000245], this report directly tests whether the bottom-line compression has been confined to the guided 5% drawdown or has deteriorated further.
What makes this event decisive, rather than subsequent quarters, is that it absorbs the sharpest concentration of input inflation from the Middle East conflict before full-year mitigating actions can take effect. Management quantified a $1.0 billion after-tax cost headwind for fiscal 2027 spanning crude-linked materials, energy, and transportation surcharges, within a broader $1.4 billion ($0.56 per share, or 8% of fiscal 2026 core EPS) total headwind from costs, foreign currency, and below-the-line items [transcript:FY2026-Q4]. Schulten explicitly noted that the bulk of this input pressure lands in the first half of fiscal 2027 because inventory flowed from periods when oil exceeded $100 per barrel [transcript:FY2026-Q4]. Because short-term cost-of-goods-sold offsets and productivity maneuvers cannot be fully stood up immediately, the Q1 report settles whether core gross margin and operating margin hold up sufficiently to keep the full-year core EPS target of $6.89 to $7.11 (0% to 3% growth over fiscal 2026's $6.89) within reach [transcript:FY2026-Q4].
The second critical issue this release resolves is whether North American shipments reconnect with underlying consumption. In the fourth quarter of fiscal 2026, North American organic sales fell 1% despite 2% consumption growth, creating a 3-percentage-point disconnect caused by customer inventory reductions and the timing shift of Amazon Prime Day [transcript:FY2026-Q4]. The October 22 report is the first marker showing whether retailer ordering has normalized and whether volume can re-enter positive territory to validate management's fiscal 2027 full-year organic sales growth target of 1% to 3% [transcript:FY2026-Q4].
Regarding the evidence base: the earnings call transcripts throughout fiscal 2026 are truncated and do not contain reported financial tables, and the Form 10-K filing excerpt for fiscal 2026 cuts off prior to the Item 8 financial statements [0000080424-26-000103]. Full audited statements for the fourth quarter and full fiscal year 2026 were therefore unavailable from the primary filing text; fourth-quarter net sales ($21.20 billion), operating income ($3.95 billion derived), and diluted EPS ($1.26) are drawn from standardised financial data [financials:FY2026-Q4], supplemented by the spoken disclosures in management's commentary [transcript:FY2026-Q4].
Baseline context
Across fiscal 2026, Procter & Gamble tracked a decelerating-then-rebounding top line that finished flat, while operating earnings contracted as gross margin pressures and demand investments mounted. Management judges its operational trajectory on three primary metrics: organic sales growth (decomposed into volume, pricing, and mix), core earnings per share (core EPS), and adjusted free cash flow productivity.
### First Quarter Fiscal 2026 (Ended September 30, 2025)
* **Reported Revenue and Income:** Net sales reached $22,386 million, up 3.0% from $21,737 million in the prior-year period [0000080424-25-000245]. Operating income rose 1.0% to $5,856 million from $5,797 million [0000080424-25-000245]. Net earnings attributable to Procter & Gamble were $4,750 million, up 20.0% from $3,959 million (which had absorbed $554 million in other non-operating expenses compared to $268 million in net non-operating income in Q1 FY2026) [0000080424-25-000245]. Diluted net earnings per share were $1.95, up 21.1% from $1.61 [0000080424-25-000245].
* **Company Operating Metrics:** Organic sales grew 2%, with volume flat, pricing adding 1%, and product mix adding 1% [transcript:FY2026-Q1]. Core EPS was $1.99, an increase of 3% (3% currency-neutral) [transcript:FY2026-Q1]. Core gross margin fell 50 basis points, while core operating margin was unchanged as 230 basis points of productivity savings were reinvested into innovation and commercial support [transcript:FY2026-Q1]. Adjusted free cash flow productivity reached 102% [transcript:FY2026-Q1].
* **Balance Sheet and Capital Deployment:** Cash and cash equivalents stood at $11,171 million [0000080424-25-000245]. Debt due within one year was $11,631 million and long-term debt was $24,315 million, bringing total debt to $35,946 million [0000080424-25-000245, financials:FY2026-Q1]. The company deployed $3.8 billion to shareowners, consisting of $2.55 billion in dividends and $1.25 billion in share repurchases [transcript:FY2026-Q1].
### Second Quarter Fiscal 2026 (Ended December 31, 2025)
* **Reported Revenue and Income:** Net sales were $22,208 million, up 1.5% compared to $21,882 million in the prior-year quarter [0000080424-26-000011]. Operating income dropped 6.5% to $5,366 million from $5,741 million as cost of products sold and SG&A expanded faster than top-line receipts [0000080424-26-000011]. Net earnings attributable to Procter & Gamble fell 6.7% to $4,319 million from $4,630 million [0000080424-26-000011]. Diluted EPS declined 5.3% to $1.78 from $1.88 [0000080424-26-000011].
* **Company Operating Metrics:** Organic sales were flat (0%), driven by volume down 1%, pricing up 1%, and mix flat [transcript:FY2026-Q2]. Results absorbed base-period comparison drag from prior-year port strikes and hurricane pantry loading, concentrated in North American volume (down 3%) and Family Care (down approximately 10%) [transcript:FY2026-Q2]. Core EPS was flat at $1.88 ($1.85 currency-neutral) [transcript:FY2026-Q2]. Core gross margin decreased 50 basis points and core operating margin contracted 70 basis points (down 80 basis points currency-neutral), despite 270 basis points of productivity gains [transcript:FY2026-Q2]. Adjusted free cash flow productivity fell to 88% [transcript:FY2026-Q2].
* **Balance Sheet and Capital Deployment:** Cash and cash equivalents totaled $10,825 million [0000080424-26-000011]. Debt due within one year stood at $11,062 million and long-term debt rose to $25,577 million, yielding total debt of $36,639 million [0000080424-26-000011, financials:FY2026-Q2]. P&G returned $4.8 billion of capital, distributing $2.5 billion in dividends and repurchasing $2.3 billion in stock [transcript:FY2026-Q2] (standardised financial records reflect $2,278 million in repurchases [financials:FY2026-Q2]).
### Third Quarter Fiscal 2026 (Ended March 31, 2026)
* **Reported Revenue and Income:** Net sales rose 7.4% to $21,235 million against $19,776 million in the prior-year period [0000080424-26-000060]. Operating income was virtually unchanged, ticking up 0.4% to $4,576 million from $4,558 million as gross cost increases offset top-line growth [0000080424-26-000060]. Net earnings attributable to Procter & Gamble grew 4.3% to $3,932 million from $3,769 million, aided by other non-operating income of $537 million versus $210 million [0000080424-26-000060]. Diluted EPS increased 5.8% to $1.63 from $1.54 [0000080424-26-000060].
* **Company Operating Metrics:** Organic sales expanded over 3%, driven by volume growth of 2 points, pricing up 1 point, and flat mix [transcript:FY2026-Q3]. Core EPS increased 3% to $1.59 (flat currency-neutral) [transcript:FY2026-Q3]. Core gross margin contracted 100 basis points and core operating margin dropped 80 basis points (down 70 basis points currency-neutral), as 330 basis points of productivity savings were outstripped by reinvestment in brand communication and emerging energy/logistics cost shocks [transcript:FY2026-Q3]. Adjusted free cash flow productivity softened to 82% [transcript:FY2026-Q3].
* **Balance Sheet and Capital Deployment:** Cash and cash equivalents increased to $12,306 million [0000080424-26-000060]. Debt due within one year increased sharply to $13,174 million, while long-term debt fell to $23,852 million, for total debt of $37,026 million [0000080424-26-000060, financials:FY2026-Q3]. Cash returns totaled $3.2 billion ($2.5 billion in dividends, reflecting a newly announced 3% increase, and over $600 million in repurchases) [transcript:FY2026-Q3].
### Fourth Quarter and Full Fiscal Year 2026 (Ended June 30, 2026)
* **Reported Revenue and Income:** Because the excerpted Form 10-K cuts off prior to the Item 8 financial statement tables [0000080424-26-000103], fourth-quarter GAAP figures are provided by standardised financial data: revenue was $21,203 million, derived operating income fell to $3,950 million, net income dropped to $2,997 million, and diluted EPS was $1.26 [financials:FY2026-Q4].
* **Company Operating Metrics:** In Q4, organic sales growth was flat, rounding down from modest positive gains (volume flat, price neutral, mix neutral) [transcript:FY2026-Q4]. Core EPS declined 3% to $1.43 (down 5% currency-neutral), absorbing roughly $0.06 per share of input inflation partially offset by tariff refunds [transcript:FY2026-Q4]. Core operating margin declined 130 basis points despite 460 basis points of productivity savings [transcript:FY2026-Q4]. Adjusted free cash flow productivity spiked to 133% [transcript:FY2026-Q4]. For the full fiscal year 2026, organic sales grew more than 1% (volume up modestly, pricing up 1%, mix neutral, absorbing a 40-basis-point drag from restructuring exits) [transcript:FY2026-Q4]. Full-year core EPS grew 1% to $6.89 (flat currency-neutral) [transcript:FY2026-Q4]. Core gross margin fell 40 basis points and core operating margin dropped 70 basis points (down 60 basis points currency-neutral), while free cash flow productivity finished at 100% [transcript:FY2026-Q4].
* **Balance Sheet and Capital Deployment:** As of June 30, 2026, cash and short-term investments totaled $9,942 million and total debt was $35,026 million (a detailed breakout between short-term maturities and long-term notes is absent from the truncated 10-K text and standardised records) [0000080424-26-000103, financials:FY2026-Q4]. Undrawn committed credit facilities are not stated anywhere in the supplied filings. Q4 capital distributions were $3.5 billion ($2.6 billion in dividends, roughly $900 million in share repurchases), completing over $15 billion returned across fiscal 2026 (over $10 billion in dividends and $5 billion in share repurchases) [transcript:FY2026-Q4].
### Balance-Sheet Commitments Constraining Fiscal 2027
Management enters fiscal 2027 with three pre-committed cash calls:
1. **Shareholder Returns:** Management guided plans to return roughly $15 billion in cash during fiscal 2027, comprising over $10 billion in dividends and approximately $5 billion in common stock repurchases [transcript:FY2026-Q4].
2. **Capital Spending:** Capital expenditures are committed at 4.5% to 5.5% of net sales to support category capacity expansions and automation [transcript:FY2026-Q4].
3. **Restructuring Program:** Under the multi-year program initiated in late fiscal 2025, P&G is reducing up to 7,000 nonmanufacturing roles (15% of nonmanufacturing headcount) through fiscal 2027 while reconfiguring supply chains in enterprise markets (such as Pakistan and India), requiring ongoing cash severance and implementation outlays that weigh on near-term cash conversion [transcript:FY2026-Q1, transcript:FY2026-Q2]. Together with a guided $1.4 billion after-tax ($0.56 per share) earnings drag from input inflation, foreign exchange, and net interest expenses, these outlays set the operational hurdles for the incoming fiscal year [transcript:FY2026-Q4].
What has to go right
* **Core EPS decline in Q1 FY2027 must not exceed the guided drawdown of 5% (holding at or above $1.89 per share against prior-year Q1 core EPS of $1.99):** Management took the unusual step of offering explicit single-quarter bottom-line guidance to warn that the front-loaded impact of Middle East conflict cost inflation and logistics surcharges would produce a drop of "5% or more" [transcript:FY2026-Q4]. Delivering core EPS above roughly $1.89 keeps the company on track for full-year core EPS of $6.89 to $7.11 (0% to 3% growth over FY2026's $6.89), whereas a steeper contraction would require historically unprecedented second-half acceleration against guided $1.4 billion after-tax cost and below-the-line headwinds [transcript:FY2026-Q4].
*Will the upcoming event test it?* **Yes.** This earnings release directly reports Q1 FY2027 core EPS.
* **Full-year fiscal 2027 organic sales growth guidance of 1% to 3% must be reaffirmed:** The company's top-line algorithm assumes underlying market value growth of 1% to 3% and factors in a 30- to 50-basis-point structural drag from surgical product, category, and market restructuring exits [transcript:FY2026-Q4]. Reaffirming this guidance range confirms that the 3-point gap between North American sell-out (+2%) and sell-in (-1%) recorded in Q4 FY2026 was transitory trade-inventory destocking rather than structural demand destruction [transcript:FY2026-Q4].
*Will the upcoming event test it?* **Yes.** The Q1 release will include management's updated full-year outlook.
* **Full-year fiscal 2027 core EPS guidance of $6.89 to $7.11 (0% to 3% growth) must be reaffirmed:** This baseline absorbs approximately $1.0 billion after tax in higher commodity, energy, and transportation costs (predicated on an effective Brent crude oil price of $90 per barrel flowing through inventory), a $50 million after-tax foreign exchange headwind, $150 million after tax in higher net interest expense, and $150 million after tax in lower non-operating income [transcript:FY2026-Q4]. Maintaining this range verifies that non-commodity surcharges and force majeure supplier premiums have not breached budgeted allowances [transcript:FY2026-Q4].
*Will the upcoming event test it?* **Yes.** Full-year EPS guidance will be updated or reiterated in the Q1 release.
* **Global aggregate market share must hold flat or improve sequentially (at least 25 of top 50 category-country combinations holding or gaining share):** Aggregate global market share stabilized to flat by the exit of fiscal 2026, supported by 26 of 50 top combinations holding or gaining share for the full year (though slipping to 23 of 50 in Q4) [transcript:FY2026-Q4]. Holding share demonstrates that competitors are not capitalizing on P&G's pricing adjustments and that heightened promotional aggressiveness in North American Fabric Care and Baby Care is being contained by brand superiority investments [transcript:FY2026-Q1, transcript:FY2026-Q4].
*Will the upcoming event test it?* **Yes.** Management reports quarterly global aggregate share movement and top-50 combination counts on each earnings call.
* **Full-year adjusted free cash flow productivity guidance must remain within 85% to 90%:** Delivering against this range is necessary to support capital expenditures budgeted at 4.5% to 5.5% of net sales, absorb upfront cash charges from the 7,000 nonmanufacturing role reductions, and fund the planned $15 billion cash return to shareowners ($10 billion in dividends and $5 billion in share repurchases) [transcript:FY2026-Q1, transcript:FY2026-Q4].
*Will the upcoming event test it?* **Partially.** The release will report quarterly free cash flow productivity (which can be volatile, having swung from 82% in Q3 FY2026 to 133% in Q4 FY2026) and will reiterate or adjust the full-year 85% to 90% target [transcript:FY2026-Q3, transcript:FY2026-Q4].
* **Execution of up to 7,000 nonmanufacturing workforce reductions (up to 15% of nonmanufacturing roles) through fiscal 2027 must remain on track:** Management committed to this two-year organizational restructuring across FY2026 and FY2027 to transition to smaller, digitally enabled brand teams and generate cost savings to fund demand creation [transcript:FY2026-Q1].
*Will the upcoming event test it?* **No.** Headcount restructuring progress is reported qualitatively across multi-quarter phases and will not be settled by a single quarter's figures.
* **Annual gross cost-of-goods-sold savings run rate must track toward the target of up to $1.5 billion before tax:** Management relies on these Supply Chain 3.0 platform efficiencies to offset ongoing tariff costs (which ran at approximately $500 million before tax in fiscal 2026) and fund reinvestment in vectors of brand superiority [transcript:FY2026-Q1].
*Will the upcoming event test it?* **No.** Supply chain productivity programs are assessed on multi-year rolling master plans, though quarterly gross productivity basis points provide directional evidence.
Bull, base, and bear
### Bull
*Core EPS reaches or exceeds $1.90 per share as volume recovery beats the guided 5% cost decline and management lifts the full-year core EPS guidance midpoint to $7.11 per share or higher.*
* **Core earnings per share (core EPS):** At or above $1.90 per share for the first quarter of fiscal 2027, restricting bottom-line contraction to under 4.5% versus prior-year Q1 core EPS of $1.99 [transcript:FY2026-Q1] and outperforming management's guidance of a decline of 5% or more [transcript:FY2026-Q4].
* **Organic sales growth:** At or above 3.0% for the first quarter of fiscal 2027, reaching the upper ceiling of management's full-year target of 1% to 3% [transcript:FY2026-Q4] as North American shipments re-accelerate to match consumption after Q4 FY2026 destocking [transcript:FY2026-Q4].
* **Net sales:** At or above $22,834 million for the first quarter of fiscal 2027, generating at least 2.0% reported revenue growth computed from prior-year Q1 net sales of $22,386 million [0000080424-25-000245].
* **Diluted net earnings per common share:** At or above $1.86 per share for the first quarter of fiscal 2027, limiting GAAP earnings per share compression to under 4.6% against Q1 FY2026 diluted EPS of $1.95 [0000080424-25-000245].
* **Full-year fiscal 2027 core EPS guidance midpoint:** At or above $7.11 per share, as management raises full-year core EPS expectations above the initial range of $6.89 to $7.11 per share [transcript:FY2026-Q4] following strong supply chain reformulation and pricing realization.
### Neutral
*Core EPS lands between $1.80 and $1.90 per share, confirming management's guided 5% commodity drawdown while organic sales grow 1.0% to 3.0% and full-year core EPS guidance is reiterated at $6.89 to $7.11 per share.*
* **Core earnings per share (core EPS):** $1.80 to $1.90 per share for the first quarter of fiscal 2027, aligning with management's explicit warning that input costs from the Middle East conflict would drive Q1 EPS down 5% or more from prior-year Q1 core EPS of $1.99 ($1.99 multiplied by 0.95 equals $1.89) [transcript:FY2026-Q1, transcript:FY2026-Q4].
* **Organic sales growth:** 1.0% to 3.0% for the first quarter of fiscal 2027, tracking squarely within management's full-year outlook of 1% to 3% and absorbing a 30 to 50 basis point drag from portfolio restructuring exits [transcript:FY2026-Q4].
* **Net sales:** $22,386 million to $22,834 million for the first quarter of fiscal 2027, spanning 0.0% to 2.0% reported growth over net sales of $22,386 million in the first quarter of fiscal 2026 [0000080424-25-000245].
* **Diluted net earnings per common share:** $1.75 to $1.86 per share for the first quarter of fiscal 2027, reflecting a GAAP earnings contraction of 4.6% to 10.3% against Q1 FY2026 diluted EPS of $1.95 [0000080424-25-000245].
* **Full-year fiscal 2027 core EPS guidance midpoint:** $6.89 to $7.11 per share, as management reiterates its full-year core EPS outlook of $6.89 to $7.11 per share ($7.00 midpoint) [transcript:FY2026-Q4].
### Bear
*Core EPS drops to or below $1.80 per share as unhedged Middle East logistics surcharges outpace productivity savings and force a reduction in full-year core EPS guidance midpoint to $6.89 per share or lower.*
* **Core earnings per share (core EPS):** At or below $1.80 per share for the first quarter of fiscal 2027, reflecting a contraction of more than 9.5% versus prior-year Q1 core EPS of $1.99 [transcript:FY2026-Q1] as unhedged Middle East freight surcharges and supplier force majeure costs exceed the guided 5% drawdown [transcript:FY2026-Q4].
* **Organic sales growth:** At or below 1.0% for the first quarter of fiscal 2027, landing at or below the bottom of management's full-year guidance range of 1% to 3% [transcript:FY2026-Q4] as the 3-percentage-point trade inventory gap between sell-in and sell-out from Q4 FY2026 persists in North America amid aggressive category promotions [transcript:FY2026-Q1, transcript:FY2026-Q4].
* **Net sales:** At or below $22,386 million for the first quarter of fiscal 2027, representing zero or negative reported sales growth compared to net sales of $22,386 million in the first quarter of fiscal 2026 [0000080424-25-000245].
* **Diluted net earnings per common share:** At or below $1.75 per share for the first quarter of fiscal 2027, representing a decline of at least 10.3% from $1.95 in the first quarter of fiscal 2026 [0000080424-25-000245].
* **Full-year fiscal 2027 core EPS guidance midpoint:** At or below $6.89 per share, as management lowers the full-year core EPS target below the initial range of $6.89 to $7.11 per share [transcript:FY2026-Q4] to absorb front-loaded cost inflation without second-half recovery.
Management credibility
### Sequence of Prior Commitments and Outturns
Tracking management’s statements across the earnings calls of fiscal 2026 reveals a high level of forecasting accuracy and directional discipline, with executives consistently setting, refining, and meeting operational targets.
#### First Quarter Fiscal 2026 Call (October 2025)
* **The Commitment:** Chief Financial Officer Andre Schulten established full-year fiscal 2026 targets of organic sales growth "in line to plus 4%" (0% to 4%), core earnings per share (EPS) growth "in line to plus 4%, which equates to a range of $6.83 to $7.09 per share or $6.96, up 2% in the center of the range," and adjusted free cash flow productivity "in the range of 85% to 90%" [transcript:FY2026-Q1]. He pre-announced capital distributions of "around $10 billion in dividends and to repurchase approximately $5 billion in common stock, combined a plan to return roughly $15 billion of cash" [transcript:FY2026-Q1]. Addressing intra-year cadence, Schulten committed to a specific trajectory: base-period distortions from prior-year port strikes would "likely result in quarter 2 this year being the softest growth quarter for the year with stronger growth in the back half" [transcript:FY2026-Q1].
* **The Following Outturn:** In the second quarter of fiscal 2026, organic sales growth came in at 0% ("in line with the prior year"), exactly fulfilling the projection that Q2 would be the year's top-line trough [transcript:FY2026-Q2]. Core EPS was flat at $1.88, while adjusted free cash flow productivity reached 88%, tracking squarely inside the annual guidance band [transcript:FY2026-Q2]. Net sales were $22,208 million and diluted EPS was $1.78 [0000080424-26-000011].
#### Second Quarter Fiscal 2026 Call (January 2026)
* **The Commitment:** Management reiterated all full-year fiscal 2026 guidance bands (organic sales 0% to 4%, core EPS $6.83 to $7.09, cash returns of roughly $15 billion) [transcript:FY2026-Q2]. Schulten and Chief Executive Officer Shailesh Jejurikar reinforced the second-half inflection commitment, stating they "anticipated this would be the softest quarter of the fiscal year and we remain confident in stronger growth in the back half" driven by commercial interventions in the U.S. and sustained momentum in international markets [transcript:FY2026-Q2].
* **The Following Outturn:** In the third quarter of fiscal 2026, organic sales growth accelerated sharply to "more than 3%" (supported by 2 points of volume growth and 1 point of pricing), validating the second-half acceleration commitment [transcript:FY2026-Q3]. Core EPS increased 3% to $1.59 [transcript:FY2026-Q3]. Reported net sales rose 7.4% to $21,235 million, and diluted EPS reached $1.63 [0000080424-26-000060]. Adjusted free cash flow productivity softened to 82%, but full-year tracking remained viable [transcript:FY2026-Q3].
#### Third Quarter Fiscal 2026 Call (April 2026)
* **The Commitment:** Confronting Middle East energy and logistics shocks, management maintained full-year ranges (organic sales 0% to 4%, core EPS $6.83 to $7.09) but provided two explicit granular adjustments [transcript:FY2026-Q3]. First, for Q4 cadence, Schulten guided that March trade-inventory build ahead of Easter would "result in fourth quarter organic sales somewhat lower than third quarter" [transcript:FY2026-Q3]. Second, factoring in a concentrated $150 million after-tax Middle East cost headwind hitting Q4, management explicitly guided that full-year core EPS would land "towards the lower end of the guidance range" [transcript:FY2026-Q3].
* **The Following Outturn:** At the fiscal 2026 year-end call, management reported that Q4 organic sales "increased modestly, rounding down to in line versus prior year" (0%), correctly landing below Q3's >3% pace [transcript:FY2026-Q4]. For the full year, organic sales grew "more than 1%," within the original 0% to 4% range [transcript:FY2026-Q4]. Full-year core EPS was $6.89 (+1%), delivering squarely within the $6.83 to $7.09 range and precisely hitting the guided "lower end" [transcript:FY2026-Q4]. Full-year adjusted free cash flow productivity reached 100% (driven by 133% in Q4), beating the 85% to 90% target [transcript:FY2026-Q4]. Total cash returned to shareowners exceeded $15 billion (over $10 billion in dividends and $5 billion in repurchases), matching guidance [transcript:FY2026-Q4].
### The Track Record Pattern
Management has met or exceeded every checkable guidance figure and quarterly pacing commitment made across fiscal 2026. Across seven specific, verifiable commitments evaluated over the year:
* **Full-year organic sales growth:** Met (guided 0% to 4%; reported >1%) [transcript:FY2026-Q1, transcript:FY2026-Q4].
* **Full-year core EPS:** Met (guided $6.83 to $7.09; reported $6.89, fulfilling the Q3 narrowing to the lower end) [transcript:FY2026-Q1, transcript:FY2026-Q3, transcript:FY2026-Q4].
* **Full-year adjusted free cash flow productivity:** Beat (guided 85% to 90%; reported 100%) [transcript:FY2026-Q1, transcript:FY2026-Q4].
* **Full-year capital returns to shareowners:** Met (guided ~$15 billion; reported >$15 billion) [transcript:FY2026-Q1, transcript:FY2026-Q4].
* **Q2 pacing trough:** Met (projected softest quarter; reported 0% organic sales vs. 2% in Q1 and >3% in Q3) [transcript:FY2026-Q1, transcript:FY2026-Q2, transcript:FY2026-Q3].
* **Second-half top-line acceleration:** Met (projected H2 acceleration; delivered +2% organic sales in H2 vs. +1% in H1) [transcript:FY2026-Q2, transcript:FY2026-Q4].
* **Q4 moderation vs. Q3:** Met (projected Q4 lower than Q3; delivered 0% vs. >3%) [transcript:FY2026-Q3, transcript:FY2026-Q4].
In total, management met six and beat one of its seven checkable operational statements, with zero misses.
### Open Commitments Entering Fiscal 2027
Several structural and financial commitments remain active and unjudged, establishing the benchmark for the upcoming release:
* **Q1 FY2027 Core EPS Drawdown:** Management broke normal protocol to offer single-quarter guidance, projecting that Middle East cost inflation and freight surcharges will cause Q1 core EPS to be "down 5% or more versus prior year" (implying $1.89 or lower against Q1 FY2026 core EPS of $1.99) [transcript:FY2026-Q1, transcript:FY2026-Q4]. *Status: Open.*
* **Full-Year FY2027 Organic Sales Growth:** Guided at 1% to 3%, incorporating a 30 to 50 basis point drag from surgical restructuring exits [transcript:FY2026-Q4]. *Status: Open.*
* **Full-Year FY2027 Core EPS:** Guided at $6.89 to $7.11 (0% to 3% growth over FY2026's $6.89), absorbing an estimated $1.0 billion after-tax cost headwind ($90 Brent crude baseline) and $1.4 billion ($0.56 per share) in total cost and below-the-line headwinds [transcript:FY2026-Q4]. *Status: Open.*
* **Full-Year FY2027 Free Cash Flow and Capital Return:** Guided adjusted free cash flow productivity of 85% to 90%, capital spending at 4.5% to 5.5% of net sales, and roughly $15 billion returned to shareholders (over $10 billion in dividends, ~$5 billion in buybacks) [transcript:FY2026-Q4]. *Status: Open.*
* **Headcount and Operational Restructuring:** A commitment to "reduce up to 7,000 nonmanufacturing roles or up to 15% of our current nonmanufacturing workforce over this fiscal year [FY2026] and fiscal '27" [transcript:FY2026-Q1]. *Status: Open.*
* **COGS Productivity Target:** Gross savings objective in cost of goods sold of "up to $1.5 billion before tax" enabled by Supply Chain 3.0 [transcript:FY2026-Q1]. Full-year FY2026 achieved $2.8 billion before tax of gross productivity across COGS and SG&A combined [transcript:FY2026-Q4]. *Status: Open.*
* **Product Rollouts:** National expansion and full-scale launch support for Tide Evo during fiscal 2027 [transcript:FY2026-Q4]. *Status: Open.*
### Language and Credibility Watchpoints
On the October 22, 2026 earnings call, specific phrasing and disclosures will indicate whether management's execution matches its guided parameters:
1. **Quantification of the Q1 Bottom Line:** Listen for whether core EPS declines beyond the warned threshold of "5% or more" [transcript:FY2026-Q4]. If core EPS drops past 8% to 10% (below ~$1.83), listen for whether management attributes the variance to higher-than-expected "force majeure premiums" and non-commodity freight surcharges rather than commodity prices, which were budgeted at an effective $90 Brent crude [transcript:FY2026-Q4].
2. **Reaffirmation of Full-Year FY2027 Guidance:** Check whether management maintains the core EPS range of $6.89 to $7.11 or lowers the range [transcript:FY2026-Q4]. A reduction in full-year EPS guidance would signal that short-term productivity and selective pricing cannot offset front-loaded input costs.
3. **Resolution of North American Trade Destocking:** In Q4 FY2026, North American organic shipments trailed consumption by 3 percentage points (-1% sell-in versus +2% sell-out) due to retailer inventory cuts and Prime Day calendar shifts [transcript:FY2026-Q4]. Listen for explicit confirmation that "shipments were largely in line with offtake" in North America during Q1, mirroring the phrasing used after earlier inventory swings [transcript:FY2026-Q1]. Any continuation of a sell-in deficit indicates retailer resistance rather than temporary timing.
4. **Market Share Trajectory:** Management exited fiscal 2026 with aggregate global share "flat" but with top-50 category-country combinations holding or gaining share slipping to 23 of 50 in Q4 (down from 26 in Q3) [transcript:FY2026-Q3, transcript:FY2026-Q4]. Listen for whether combination share metrics rebound to 25 or more, validating claims that brand superiority investments are overcoming promotional rollbacks in U.S. Fabric Care and Baby Care [transcript:FY2026-Q1, transcript:FY2026-Q2].
5. **Restructuring Severance and Role Progress:** Listen for qualitative updates confirming progress on the nonmanufacturing headcount reduction toward the 7,000-role target [transcript:FY2026-Q1]. Delays or unexpected friction in organizational redesign would jeopardize the overhead reductions intended to fund back-half marketing.
*(Note on evidence base: Transcripts for fiscal 2026 are truncated and lack financial statement tables; the Form 10-K excerpt terminates prior to Item 8. Fourth-quarter GAAP figures are corroborated through standardised financial data [financials:FY2026-Q4], while segment, organic sales, and core EPS metrics reflect spoken commentary from executive disclosures [transcript:FY2026-Q4].)*